Overview
Patients will be randomized to receive treatment with either a total of 20 U of botulinum toxin(diluted in saline to a concentration of 50 U per milliliter.
Description
Lateral internal sphincterotomy, the most common treatment for chronic anal fissure, may cause permanent injury to the anal sphincter, which can lead to fecal incontinence. We compared two nonsurgical treatments that avert the risk of fecal incontinence.treatment with either topical nitroglycerin or botulinum toxin is effective as an alternative to surgery
Eligibility
Inclusion Criteria:
- Clinical diagnosis: evidence of posterior circumscribed ulcer, with a large sentinel tag of skin, induration at the edges, and exposure of the horizontal fibers of the internal anal sphincter
- symptoms (post-defecatory or nocturnal pain, bleeding, or both) lasting for more than two months.
Exclusion Criteria:
- Patients with acute fissure
- fissure associated with other conditions (i.e., inflammatory bowel diseases, HIV infection, hemorrhoids, fistula in ano, anal abscesses, or anal or perianal cancer)
- those who had undergone previous surgical procedures in the anal canal.
- known hypersensitivity to component of the formulations of type A BTX
- pregnant or breast-feeding women 6-refusal of consent